Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Cocrystal Pharma, Inc. (COCP) had Return on Investments of -303.07% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.10M |
|
$-3.16M |
|
-- |
|
$0.10M |
|
$3.29M |
|
$-3.18M |
|
$0.02M |
|
$-3.16M |
|
$-3.16M |
|
$-3.16M |
|
$-3.16M |
|
$-3.16M |
|
$-3.16M |
|
$-3.18M |
|
$-3.01M |
|
13.79M |
|
13.79M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$3.24M |
|
$0.07M |
|
$1.41M |
|
$4.65M |
|
$2.62M |
|
-- |
|
$0.99M |
|
$3.60M |
|
$1.04M |
|
$1.04M |
|
$1.04M |
|
13.79M |
|
| Cash Flow Statement Financials | |
$-4.86M |
|
-- |
|
-- |
|
$7.10M |
|
$2.24M |
|
$-4.86M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3032.38% |
|
-3032.38% |
|
-- |
|
-3013.33% |
|
-3013.33% |
|
$-4.86M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.14 |
|
630.86 |
|
-303.06% |
|
-303.07% |
|
-68.06% |
|
|
Return on Investments |
-303.07% |
$0.08 |
|
$-0.35 |
|
$-0.35 |
|